Pattern of Primary Resistance of Helicobacter pylori to Metronidazole or Clarithromycin in the United States
Open Access
- 14 May 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (9) , 1217-1220
- https://doi.org/10.1001/archinte.161.9.1217
Abstract
ANTIBIOTIC treatment of Helicobacter pylori infection is complex, requiring multiple antibiotics combined with acid suppressive agents to ensure high cure rates. Treatment failure is attributed generally to the lack of compliance with the drug regimen or to acquired antibiotic resistance of the organism.1,2 Emergence of resistant H pylori has been documented in various countries and threatens to compromise current treatment regimens.1-12 However, data on resistance are generally obtained from unique subsets of populations over a short period. There are few data regarding the resistance rates in the United States.This publication has 12 references indexed in Scilit:
- Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four yearsDiagnostic Microbiology and Infectious Disease, 1999
- Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United StatesInternational Journal of Antimicrobial Agents, 1999
- Antibiotic resistance problems with Helicobacter pyloriInternational Journal of Antimicrobial Agents, 1999
- A Practical Approach to Patients with Refractory Helicobacter pylori Infection, or Who Are Re-Infected After Standard TherapyDrugs, 1999
- Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patientsAustralian and New Zealand Journal of Medicine, 1998
- Antibiotic resistance in Helicobacter pylori infection.British Medical Bulletin, 1998
- Antimicrobial resistance in Helicobacter pylori: a global overviewPublished by Springer Nature ,1998
- Antimicrobial treatment of Helicobacter pylori infection.Clinical Infectious Diseases, 1997
- Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1997
- Prevalence of primaryHelicobacter pylori resistance to metronidazole and clarithromycin in The NetherlandsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996